| Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the Gruppo Oncologico Dell’Italia Meridionale G Colucci, V Gebbia, G Paoletti, F Giuliani, M Caruso, N Gebbia, ... Journal of Clinical Oncology 23 (22), 4866-4875, 2005 | 988 | 2005 |
| Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy … P Maione, F Perrone, C Gallo, L Manzione, FV Piantedosi, S Barbera, ... Journal of Clinical Oncology 23, 6865-6872, 2005 | 565 | 2005 |
| Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo F Dieli, N Gebbia, F Poccia, N Caccamo, C Montesano, F Fulfaro, ... Blood 102 (6), 2310-2311, 2003 | 317 | 2003 |
| Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial S Pignata, G Scambia, G Ferrandina, A Savarese, R Sorio, E Breda, ... Journal of clinical oncology 29 (27), 3628-3635, 2011 | 262 | 2011 |
| Topotecan compared with no therapy after response to surgery and carboplatin/paclitaxel in patients with ovarian cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1 … S De Placido, G Scambia, G Di Vagno, E Naglieri, AV Lombardi, ... Journal of clinical oncology 22 (13), 2635-2642, 2004 | 186 | 2004 |
| Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia … V Bazan, V Agnese, S Corsale, V Calo, MR Valerio, MA Latteri, S Vieni, ... Annals of oncology 16, iv50-iv55, 2005 | 170 | 2005 |
| Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: the Multicenter Italian Trial in Ovarian … S Pignata, S De Placido, R Biamonte, G Scambia, G Di Vagno, G Colucci, ... BMC cancer 6, 1-7, 2006 | 147 | 2006 |
| Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients S Siragusa, C Arcara, A Malato, R Anastasio, MR Valerio, F Fulfaro, ... Annals of Oncology 16, iv136-iv139, 2005 | 106 | 2005 |
| Hepatocellular carcinoma recurrence in patients with curative resection or ablation: impact of HCV eradication does not depend on the use of interferon S Petta, G Cabibbo, M Barbara, S Attardo, L Bucci, F Farinati, EG Giannini, ... Alimentary pharmacology & therapeutics 45 (1), 160-168, 2017 | 93 | 2017 |
| Gruppo Oncologico Dell’Italia Meridionale. Phase III randomized trial of FOLFIRI versus FOLFOX4 in the treatment of advanced colorectal cancer: a multicenter study of the … G Colucci, V Gebbia, G Paoletti, F Giuliani, M Caruso, N Gebbia, ... J Clin Oncol 23 (22), 4866-4875, 2005 | 92 | 2005 |
| A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma G Cabibbo, S Petta, M Barbàra, G Missale, R Virdone, E Caturelli, ... Liver International 37 (8), 1157-1166, 2017 | 88 | 2017 |
| The evolutionary scenario of hepatocellular carcinoma in Italy: an update L Bucci, F Garuti, B Lenzi, A Pecorelli, F Farinati, EG Giannini, A Granito, ... Liver International 37 (2), 259-270, 2017 | 80 | 2017 |
| Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell … P Comella, G Filippelli, G De Cataldis, B Massidda, G Frasci, L Maiorino, ... Annals of oncology 18 (2), 324-330, 2007 | 74 | 2007 |
| Patients with cancer and COVID-19: a WhatsApp messenger-based survey of patients’ queries, needs, fears, and actions taken V Gebbia, D Piazza, MR Valerio, N Borsellino, A Firenze JCO global oncology 6, 722-729, 2020 | 73 | 2020 |
| Gemcitabine (G) in pretreated breast cancer (BC) MR Valerio, G Cicero, MG Armata, E Bajardi, A Crosta, G Badalamenti, ... Proc Am Soc Clin Oncol 20 (51b), 2001 | 69 | 2001 |
| Comparison between alcohol‐and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome L Bucci, F Garuti, V Camelli, B Lenzi, F Farinati, EG Giannini, F Ciccarese, ... Alimentary pharmacology & therapeutics 43 (3), 385-399, 2016 | 66 | 2016 |
| Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers F Verderame, A Russo, R Di Leo, G Badalamenti, D Santangelo, G Cicero, ... Annals of Oncology 17, vii68-vii72, 2006 | 66 | 2006 |
| DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study V Bazan, M Migliavacca, I Zanna, C Tubiolo, S Corsale, V Calo, A Amato, ... Journal of cancer research and clinical oncology 128, 650-658, 2002 | 64 | 2002 |
| Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents V Gebbia, G Bellavia, F Ferraù, MR Valerio Expert Opinion on Drug Safety 11 (sup1), S49-S59, 2012 | 60 | 2012 |
| Metronomic chemotherapy for advanced breast cancer patients in the real world practice: final results of the VICTOR-6 study ME Cazzaniga, G Pinotti, E Montagna, D Amoroso, R Berardi, A Butera, ... The Breast 48, 7-16, 2019 | 55 | 2019 |
